Related Experiment Video
Updated: Jun 27, 2026

Improved Swiss-rolling Technique for Intestinal Tissue Preparation for Immunohistochemical and Immunofluorescent Analyses
Published on: July 13, 2016
Notch inhibits expression of the Krüppel-like factor 4 tumor suppressor in the intestinal epithelium
Amr M Ghaleb1, Gaurav Aggarwal, Agnieszka B Bialkowska
1Division of Digestive Diseases, Department of Medicine, Emory University School of Medicine, 615 Michael Street, Atlanta, GA 30322, USA.
Abstract:
The zinc finger-containing transcription factor, Krüppel-like factor 4 (KLF4), inhibits cell proliferation. An in vivo tumor-suppressive role for KLF4 is shown by the recent finding that Klf4 haploinsufficiency in Apc(Min/+) mice promotes intestinal tumorigenesis. Studies also show that KLF4 is required for the terminal differentiation of goblet cells in the mouse intestine. The Notch signaling pathway suppresses goblet cell formation and is up-regulated in intestinal tumors. Here, we investigated the relationship between Notch signaling and KLF4 expression in intestinal epithelial cells. The rate of proliferation of HT29 human colon cancer cells was reduced when treated with the gamma-secretase inhibitor dibenzazepine to inhibit Notch signaling or small interfering RNA directed against Notch. KLF4 levels were increased in dibenzazepine-treated or Notch small interfering RNA-treated cells. Conversely, overexpression of Notch in HT29 cells reduced KLF4 levels, suppressed KLF4 promoter activity, and increased proliferation rate. Treatment of Apc(Min/+) mice with dibenzazepine resulted in a 50% reduction in the number of intestinal adenomas compared with the vehicle-treated group (P < 0.001). Both the normal-appearing intestinal mucosa and adenomas obtained from dibenzazepine-treated Apc(Min/+) mice had increased goblet cell numbers and Klf4 staining accompanied by reduced cyclin D1 and Ki-67 staining when compared with those from vehicle-treated mice. Results of these studies indicate that Notch signaling suppresses KLF4 expression in intestinal tumors and colorectal cancer cells. Inhibition of Notch signaling increases KLF4 expression and goblet cell differentiation and reduces proliferation and tumor formation. KLF4 is therefore a potential mediator for the antitumor effect of Notch inhibitors such as dibenzazepine.
Insights
Inhibition of Notch signaling boosts Krüppel-like factor 4 (KLF4) expression, promoting goblet cell differentiation and reducing intestinal tumor formation in mice. This highlights KLF4 as a mediator for Notch inhibitor efficacy.
Area of Science:
- Gastroenterology
- Molecular Biology
- Oncology
Background:
- Krüppel-like factor 4 (KLF4) is a transcription factor that inhibits cell proliferation and is crucial for goblet cell differentiation in the intestine.
- Notch signaling pathway is implicated in suppressing goblet cell formation and is often upregulated in intestinal tumors.
- KLF4 haploinsufficiency in Apc(Min/+) mice accelerates intestinal tumorigenesis, suggesting a tumor-suppressive role.
Purpose of the Study:
- To investigate the interplay between Notch signaling and KLF4 expression in intestinal epithelial cells.
- To determine the effect of modulating Notch signaling on KLF4 levels, cell proliferation, and goblet cell differentiation.
- To evaluate the therapeutic potential of inhibiting Notch signaling in a mouse model of intestinal tumorigenesis.
Main Methods:
- Utilized HT29 human colon cancer cells treated with a gamma-secretase inhibitor (dibenzazepine) or small interfering RNA (siRNA) targeting Notch to assess proliferation and KLF4 levels.
- Overexpressed Notch in HT29 cells to evaluate its impact on KLF4 expression and promoter activity.
- Administered dibenzazepine to Apc(Min/+) mice to assess its effects on intestinal adenoma formation, goblet cell differentiation, and expression of KLF4, cyclin D1, and Ki-67.
Main Results:
- Inhibition of Notch signaling in HT29 cells led to decreased proliferation and increased KLF4 levels.
- Notch overexpression in HT29 cells reduced KLF4 levels, suppressed KLF4 promoter activity, and increased proliferation.
- Dibenzazepine treatment in Apc(Min/+) mice significantly reduced intestinal adenoma number by 50% and increased goblet cell numbers and KLF4 staining in both normal mucosa and adenomas.
Conclusions:
- Notch signaling actively suppresses KLF4 expression in intestinal tumors and colorectal cancer cells.
- Inhibiting Notch signaling enhances KLF4 expression, promotes goblet cell differentiation, and reduces cell proliferation and tumor development.
- KLF4 acts as a key mediator for the antitumor effects observed with Notch inhibitors like dibenzazepine.
More Related Videos
Related Concept Videos
Role Of Notch Signalling In Intestinal Stem Cell Renewal
Direct cell-to-cell contact is needed for the activation of Notch signaling. The signal is initiated when a notch ligand binds to a receptor on an adjacent cell, also...
Notch Signaling Pathway
The Notch gene came into the limelight in 1914 after the discovery that its mutation in Drosophila melanogaster leads to a serrated (or "notched") wing margin phenotype. It was not until 1985...
Notch Signaling Pathway
The Notch gene came into the limelight in 1914 after the discovery that its mutation in Drosophila melanogaster leads to a serrated (or "notched") wing margin phenotype. It was not until 1985...
Role of Ephrin-Eph Signalling in Intestinal Stem Cell Renewal
Canonical Wnt Signaling Pathway
Renewal of Intestinal Stem Cells

